Seeing Is Believing
Currently out of the existing stock ratings of Nigel Dally, 56 are a SELL (17.67%), 147 are a HOLD (46.37%), 114 are a BUY (35.96%).
Analyst Nigel Dally works at MORGAN STANLEY with a stock forecast success ratio of 60.83% fulfilled within 224.79 days on average.
Nigel Dally’s has documented 680 price targets and ratings displayed on 24 stocks. The coverage is on Financial Services, Healthcare, Communication Services, Basic Materials sectors.
Most recent stock forecast was given on AFL, Aflac orporated at 01-Mar-2024.
Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 11/13/2023. The price target of $10 was fulfilled within 106 days with a profit of $7.89 (373.93%) receiving and performance score of 35.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
95
$9.86 (11.58%)
80
15 days ago
8/9 (88.89%)
$9.58 (11.22%)
445
Hold
80
$-5.14 (-6.04%)
80
1 months 19 days ago
25/25 (100%)
$-0.43 (-0.53%)
306
Hold
83
$-2.14 (-2.51%)
78
2 months 14 days ago
3/3 (100%)
$6.56 (8.58%)
32
Hold
84
$-1.14 (-1.34%)
80
3 months 10 days ago
4/4 (100%)
$1.88 (2.29%)
80
Hold
90
$4.86 (5.71%)
83
3 months 10 days ago
5/8 (62.5%)
$7.88 (9.60%)
98
Which stock is Nigel Dally is most bullish on?
Which stock is Nigel Dally is most reserved on?
What Year was the first public recommendation made by Nigel Dally?